The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Exploring miRNA based approaches in cancer diagnostics and therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Medina, P. P., Nolde, M., & Slack, F. J. (2010) · Nature · doi:10.1038/nature09284 · Cited by 1,073
Farazi, T. A., Spitzer, J. I., Morozov, P., & Tuschl, T. (2011) · The Journal of Pathology · doi:10.1002/path.2806 · Cited by 895
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
The role of let-7 in cell differentiation and cancer
Boyerinas, B., Park, S.-M., Hau, A., Murmann, A. E., & Peter, M. E. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0184 · Cited by 669
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
Aqeilan, R. I., Calin, G. A., & Croce, C. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.69 · Cited by 648
MicroRNAs and their regulatory roles in animals and plants
Zhang, B., Wang, Q., & Pan, X. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20869 · Cited by 556
Zhang, Y., Wang, Z., & Gemeinhart, R. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.015 · Cited by 535
Hoffman, B., & Liebermann, D. A. (2008) · Oncogene · doi:10.1038/onc.2008.312 · Cited by 488
MicroRNAs: Novel regulators in the hallmarks of human cancer
Ruan, K., Fang, X., & Ouyang, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.031 · Cited by 447
MicroRNA—implications for cancer
Sassen, S., Miska, E. A., & Caldas, C. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0532-2 · Cited by 441
MicroRNAs and their target gene networks in breast cancer
O'Day, E., & Lal, A. (2010) · Breast Cancer Research · doi:10.1186/bcr2484 · Cited by 439
The roles of microRNA in cancer and apoptosis
Lynam‐Lennon, N., Maher, S. G., & Reynolds, J. V. (2009) · Biological Reviews · doi:10.1111/j.1469-185x.2008.00061.x · Cited by 407
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., Guarnera, M., Liao, J., Chou, A., Lu, C. L., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.194 · Cited by 383
microRNA-205 Regulates HER3 in Human Breast Cancer
Iorio, M. V., Casalini, P., Piovan, C., Di Leva, G., Merlo, A., Triulzi, T., Ménard, S., Croce, C. M., & Tagliabue, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2920 · Cited by 365
miR-155 : On the Crosstalk Between Inflammation and Cancer
Tili, E., Croce, C. M., & Michaille, J.-J. (2009) · International Reviews of Immunology · doi:10.1080/08830180903093796 · Cited by 340
MicroRNA expression profiling using microarrays
Liu, C.-G., Calin, G. A., Volinia, S., & Croce, C. M. (2008) · Nature Protocols · doi:10.1038/nprot.2008.14 · Cited by 297
MicroRNA profiling: separating signal from noise
Baker, M. (2010) · Nature Methods · doi:10.1038/nmeth0910-687 · Cited by 219
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
Chen, Y., Liu, W., Chao, T., Zhang, Y., Yan, X., Gong, Y., Qiang, B., Yuan, J., Sun, M., & Peng, X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.034 · Cited by 217
Targeting miR-21 for the Therapy of Pancreatic Cancer
Sicard, F., Gayral, M., Lulka, H., Buscail, L., & Cordelier, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.35 · Cited by 217
miRNAs in cancer: approaches, aetiology, diagnostics and therapy
Blenkiron, C., & Miska, E. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm056 · Cited by 184
Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
Wozniak, M. B., Scélo, G., Muller, D. C., Mukeria, A., Zaridze, D. G., & Brennan, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125026 · Cited by 156
Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
Madhavan, D., Ćuk, K., Burwinkel, B., & Yang, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00116 · Cited by 153
Goljanek‐Whysall, K., Pais, H., Rathjen, T. M., Sweetman, D., Dalmay, T., & Münsterberg, A. (2012) · Journal of Cell Science · doi:10.1242/jcs.101758 · Cited by 137
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
Goh, J. N., Loo, S. Y., Datta, A., Siveen, K. S., Yap, W. N., Cai, W., Shin, E. M., Wang, C., Kim, J. E., Chan, M., et al. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12176 · Cited by 132
Circulating miRNAs in cancer: from detection to therapy
Wang, W., & Chen, Y. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0086-0 · Cited by 128
Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
Wang, R., Zheng, Y., Wang, P., & Zhang, J.-Z. (2015) · Europe PMC (PubMed Central) · Cited by 125
Identification and Characterization of Novel MicroRNAs from Schistosoma japonicum
Xue, X., Sun, J., Zhang, Q., Wang, Z., Huang, Y., & Pan, W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004034 · Cited by 124
Cheng, C.-Y., Hwang, C., Corney, D. C., Flesken‐Nikitin, A., Jiang, L., Öner, M. G., Munroe, R. J., Schimenti, J. C., Hermeking, H., & Nikitin, A. Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.023 · Cited by 117
Zhou, J., Tian, Y., Li, J., Lu, B., Sun, M., Zou, Y., Kong, R., Luo, Y., Shi, Y., Wang, K., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.084 · Cited by 113
MicroRNA-375 plays a dual role in prostate carcinogenesis
Costa‐Pinheiro, P., Ramalho-Carvalho, J., Vieira, F. Q., Torres-Ferreira, J., Oliveira, J., Gonçalves, C. S., Costa, B. M., Henrique, R., & Jerónimo, C. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0076-2 · Cited by 109
Markou, A. N., Yousef, G. M., Stathopoulos, E. N., Georgoulias, V., & Lianidou, E. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210542 · Cited by 106
miRNAs at the heart of the matter
Wang, Z., Luo, X., Lu, Y., & Yang, B. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0341-3 · Cited by 101
Micro RNAs: Tiny sequences with enormous potential
Shruti, K., Shrey, K., & Vibha, R. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.058 · Cited by 90
Nikitina, E., Уразова, Л. Н., & Stegny, V. N. (2012) · PubMed · Cited by 88
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
Fuziwara, C. S., & Kimura, E. T. (2014) · International Journal of Endocrinology · doi:10.1155/2014/743450 · Cited by 87
Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy
Jakopović, M., Thomas, A., Balasubramaniam, S., Schrump, D. S., Giaccone, G., & Bates, S. E. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00261 · Cited by 86
Micro RNA ‐142 is mutated in about 20% of diffuse large B ‐cell lymphoma
Klangbud, W. K., Lenze, D., Alles, J., Motsch, N., Barth, S., Döll, C., Imig, J., Hummel, M., Tinguely, M., Trivedi, P., et al. (2012) · Cancer Medicine · doi:10.1002/cam4.29 · Cited by 85
Critical analysis of the potential for microRNA biomarkers in breast cancer management
Sempere, L. F., Graveel, C. R., Calderone, H. M., Westerhuis, J. J., & Winn, M. E. (2015) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s43799 · Cited by 85
MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
Stiegelbauer, V., Perakis, S., Deutsch, A., Ling, H., Gerger, A., & Pichler, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11727 · Cited by 83
Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients
Mostert, B., Sieuwerts, A. M., Martens, J. W. M., & Sleijfer, S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.11 · Cited by 79
Mihelich, B. L., Maranville, J., Nolley, R., Peehl, D. M., & Nonn, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124245 · Cited by 71
Presneau, N., Eskandarpour, M., Shemais, T. A. H., Henderson, S. R., Halai, D., Tirabosco, R., & Flanagan, A. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.518 · Cited by 69
Zhang, Z., Bai, Z.-H., Wang, X., Bai, L., Miao, F., & Pei, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118814 · Cited by 68
Zhang, Z., Liu, Z.-B., Ren, W., Ye, X.-G., & Zhang, Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1059 · Cited by 67
Overcoming obstacles in microRNA delivery towards improved cancer therapy
Ben‐Shushan, D., Markovsky, E., Gibori, H., Tiram, G., Scomparin, A., & Satchi‐Fainaro, R. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0160-0 · Cited by 65
MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a
Ribeiro, J., & de Sousa, H. M. L. (2014) · Molecular Biology Reports · doi:10.1007/s11033-013-2998-0 · Cited by 65
Multistep Model of Cervical Cancer: Participation of miRNAs and Coding Genes
Granados‐López, A. J., & López, J. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915700 · Cited by 63
Apoptomirs: small molecules have gained the license to kill
Vecchione, A. M., & Croce, C. M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0163 · Cited by 63
MiR-155 at the heart of oncogenic pathways
Czyzyk-Krzeska, M., & Zhang, X. (2013) · Oncogene · doi:10.1038/onc.2013.26 · Cited by 61
The role of microRNAs in hematopoietic stem cell and leukemic stem cell function
Chung, S. S., Hu, W., & Park, C. Y. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711410772 · Cited by 42
Hálková, T., Čuperková, R., Minárik, M., & Benešová, L. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/892903 · Cited by 40
Non-coding RNAs for medical practice in oncology.
Setoyama, T., Hui, L., Natsugoe, S., & Calin, G. (2011) · The Keio Journal of Medicine · doi:10.2302/kjm.60.106 · Cited by 33
miR-17-92 cluster: an apoptosis inducer or proliferation enhancer
Ranji, N., Sadeghizadeh, M., Shokrgozar, M. A., Bakhshandeh, B., Karimipour, M., Amanzadeh, A., & Azadmanesh, K. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1678-7 · Cited by 32
Wu, P., Tian, Y. E., Chen, G., Wang, B., Gui, L., Xi, L., Ma, X., Fang, Y., Zhu, T., Wang, D., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.142 · Cited by 27
Proton-Beam Therapy for Prostate Cancer
Kagan, A. R., & Schulz, R. J. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181f8c25d · Cited by 20
Liao, Y.-C., Lin, T.-H., Chen, C.-Y., Lin, S.-B., & Au, L. (2014) · BioMed Research International · doi:10.1155/2014/306718 · Cited by 14
MicroRNAs Patents: The Road From Bench to Bedsides for Cancer Treatment
Wu, W. (2011) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221511796392079 · Cited by 5
Cited by
Molecular Biomarkers in Cancer
Sarhadi, V. K., & Armengol, G. (2022) · Biomolecules · doi:10.3390/biom12081021 · Cited by 467
RNAi-based therapeutics and tumor targeted delivery in cancer
Kara, G., Calin, G. A., & Ozpolat, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114113 · Cited by 411
miRNAs as therapeutic tools and biomarkers for prostate cancer
Arrighetti, N., & Beretta, G. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030380 · Cited by 43
Salemi, M., Mogavero, M. P., Lanza, G., Mongioì, L. M., Calogero, A. E., & Ferri, R. (2022) · Cells · doi:10.3390/cells11121930 · Cited by 39
Metadata
- Authors
- Mishra, S., Yadav, T., & Rani, V.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 98
- Pages
- 12-23
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2129204554
- Cited by
- 493
- References
- 60
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.